| Value | ₹20.37 Cr |
|---|
BSE filing, NSE: JUBLINGREA. Summary written from the filing by ALFA Finder's alert engine.
Jubilant Ingrevia Ltd: key numbers
- Share price
- ₹567.85
- Market cap
- ₹9,045 Cr
- Revenue (annual)
- ₹4,388 Cr
- Net profit (annual)
- ₹277.9 Cr
- P/E (TTM)
- 25.8×Sector 34.1×
- Promoter holding
- 45.22%+0.00% QoQ
- FII holding
- 6.93%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Jubilant Ingrevia Ltd
All →Jubilant Ingrevia Earnings Call Transcript: Key Takeaways
Strong Q2 performance driven by volume growth across specialty chemicals and nutrition despite price softness in China.
Jubilant Ingrevia Management Change
Jubilant Ingrevia's Sr. Vice President & Head HR, Ms. Vinita Koul, resigned effective November 6, 2026. The departure is to pursue other interests.
Jubilant Ingrevia Investor Presentation: Key Takeaways
Q2 FY27 revenue ₹1,394 Cr (+24% YoY), EBITDA ₹221 Cr (+51%, 16% margin), PAT ₹111 Cr (+61%). Pinnacle strategy continues; 40% ZettaOne stake (₹189.2 Cr) enters EDMS.
Jubilant Ingrevia Employee Stock Options
Jubilant Ingrevia board approved grant of 3,037 RSUs to eligible employees under its 2021 ESOP scheme. Vesting occurs at end of third year from grant date.
Jubilant Ingrevia Q2 FY27 Results: Net Profit ₹111.4 Cr, Up 60.3% YoY
Jubilant Ingrevia Ltd reported revenue from operations of ₹1,394 Cr (+24.4% YoY) and net profit of ₹111.4 Cr (+60.3% YoY) for Q2 FY27.
- Key figure
- Net profit ₹111.4 Cr · +60.3% YoY
Jubilant Ingrevia Other Announcement
This is the quarterly shareholding pattern filing for Jubilant Ingrevia Ltd for the period ending September 30, 2026. It is a routine regulatory submission.
Other legal & regulatory announcements
All →5Paisa Capital Legal & Regulatory
5paisa Capital Ltd received a favourable income tax order for AY 2023-24, granting relief of ₹40.03 crore against a total disputed amount of ₹42.90 crore.
- Value
- ₹40.03 Cr
5Paisa Capital Legal & Regulatory
5paisa Capital's appeal against an Income Tax order for A.Y. 2023-24 was partly allowed, granting the company relief of ₹40.03 Crore.
- Value
- ₹42.90 Cr
Max Healthcare Institute Legal & Regulatory
Max Healthcare informed the Exchange that the NCLT hearing regarding petitions against its subsidiary, Kalinga Hospital Ltd., was adjourned to October 30, 2026.
Bank of Baroda Legal & Regulatory
Bank of Baroda clarified media-reported interim applications filed by Dr. BR Shetty in the Bombay High Court. The bank says it has not been served and calls the allegations untested.
Canara Bank Legal & Regulatory
Canara Bank disclosed an RBI penalty of Rs. 7,30,000 over ATM cashout at 73 ATMs in Karnataka and Tamil Nadu. The penalty is the only quantified impact.
- Value
- ₹0.07 Cr
Rentomojo Legal & Regulatory
Rentomojo disclosed that the NCLT Bengaluru proceedings filed by Mr. Ajay Nain (CP No. 38/2026) were adjourned to December 1, 2026. No monetary amount is involved.